GUANGZHOU, China — June 24, 2026 — China Alliance of Research in High-Myopia (CHARM) Guangdong Provincial Sub-Center was officially inaugurated on June 23 at a launch event in Guangzhou, marking the alliance's first provincial-level expansion. The new center is spearheaded by Guangzhou First People's Hospital, with core technological partner from EVisionAI and WISER Optomed 欧视医疗 — the China joint venture between Finland-listed Optomed Plc (HEL: OPTOMED) and WISER. The launch represents a...

First-of-its-kind initiative brings clinical-grade eye health diagnostics to China's optical retail sector, with integrated referral pathways to top-tier hospitals GUANGZHOU, China — June 2026 — WISER ASIA, a China-based venture development and market-entry firm focused on European medtech, today announced that its portfolio company WISER Optomed Medical has launched an AI-powered fundus screening program in partnership with Oriental Vision, one of China's most established optical retail...

Recently, Petri Salonen, Chairman of Optomed, and Vuokko, Head of Technology, led core colleagues from the local operations, product and support teams to conduct an on-site inspection of the AI fundus screening pilot project in Guangzhou. The project is operated by Wiser Optomed Medical Technologies Co., Ltd., the joint venture between Optomed and Wiser in China, and is being implemented at multiple primary medical institutions in Liwan District, Guangzhou. As a key practice of the strategic...